TY  - JOUR
TI  - Neoadjuvant Pertuzumab in Breast Cancer and Associated Prognostic Factors
AU  - Can, O.
AU  - Ay, S.
AU  - Atci, M.M.
JO  - European Archives of Medical Research
PY  - 2026
VL  - 42
SP  - 156
EP  - 161
DO  - 10.14744/eamr.2025.35682
ER  -